The purpose of the prospective study is to evaluate the effectiveness and safety of Yiqitongluo granule in the treatment of stroke with qi-deficiency and blood-stasis in more than sixy hospitals all over China.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
2,197
administered after dissolved
Safety of Yiqitongluo for stroke measured by laboratory index
Time frame: change from baseline laboratory index at 28(±7) days
Effect of Yiqitongluo for stroke with mRS
mRS: modified Rankin Scale
Time frame: 90(±7) days
Effect of Yiqitongluo for stroke with syndrome of traditional Chinese medicine
Time frame: 28(±7) days
Effect of Yiqitongluo for stroke with NIHSS
NIHSS: the NIH stroke scale
Time frame: 28(±7) days
Effect of Yiqitongluo for stroke with BI
BI: Barthel Index
Time frame: 28(±7) days
Effect of Yiqitongluo for stroke with EQ-5D
The EQ-5D-3L essentially consists of 2 pages - the EQ-5D descriptive system and the EQ visual analogue scale (EQ VAS). The EQ-5D-3L descriptive system comprises the following 5 dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 3 levels: no problems, some problems, extreme problems.
Time frame: 28(±7) days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.